分子 聚動

On February 11, we were honored to present at the Healthcare Conference Taipei 2026 hosted by J.P. Morgan and UC Berkeley at The Regent Taipei. Compared to our last presentation, we have achieved important milestones 🚀, expanded our clinical footprint, and made significant progress in strengthening our bioadhesive technology. 💪 Thanks to the UC Berkeley School of Public Health for the opportunity. And thank you to everyone we had the pleasure of meeting. 😊

💪 We're honored to share that MoleculeX has been ranked 13 Biotech Company in Taiwan on F6S this January 2026. Compared to last year, we've reached several important milestones. More hospitals in Taiwan have adopted our Oral Wound Dressing, and we received our second TFDA medical device license for our new product, MuCoat. Beyond this, multiple new products in our pipeline are actively under development, and we are preparing to bring them to market this year. Step by step, we hope to help...

In this cold season ☃️ , we sincerely hope everyone is doing well and enjoying a warm and joyful Christmas. As we reach the end of 2025, it feels like the perfect moment to reflect on the milestones that shaped our year. ✨ 2025 Highlights ✨ 🚀 At the beginning of the year, we joined the X. health Japan program, led by Encognize G.K. and xCARE. With the support of this program, we clarified our Japan market entry strategy and had the opportunity to meet many partners during Japan Health 2025...